Abstract
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects. Historically, therapeutic options for TR were limited to surgical approaches, which are often complicated by significant morbidity and mortality in elderly patients with multiple comorbidities. This gap in therapeutic options led to the rapid evolution of transcatheter tricuspid valve intervention (TTVI), with a wide variety of approaches pursued and early results suggesting that TTVI improves clinical outcomes. Numerous strategies, including edge-to-edge repair, annular reduction, spacers, caval valve implantation, and transcatheter tricuspid valve replacement form the basis of TTVI today. In this review, the authors discuss the current state of each approach.
Original language | English (US) |
---|---|
Article number | e12 |
Journal | US Cardiology Review |
Volume | 15 |
DOIs | |
State | Published - 2021 |
Keywords
- TTVI
- TTVR
- Transcatheter
- Tricuspid regurgitation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine